If You Invested $3,000 in CRISPR Therapeutics in 2018, This Is How Much You Would Have Today
CRISPR Therapeutics (NASDAQ:CRSP) is one of the most exciting biotechs on the market today, because it’s pushing the limits of what is possible when it comes to treating hereditary diseases. It’s all made possible by the company’s gene-editing technology,…
